Citation Impact
Citing Papers
Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.
1992
Risk Factors for Venous Thromboembolism
2003 Standout
PAR3 is a cofactor for PAR4 activation by thrombin
2000 Nature
Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?
1992
Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy A prospective trial
1992
Hydrogels in Regenerative Medicine
2009 Standout
Human Fibrinogen
1988
Thromboembolic disease prophylaxis in total knee arthroplasty using intraoperative heparin and postoperative pneumatic foot compression
1999
EFFECT OF MECHANICAL COMPRESSION ON THE PREVALENCE OF PROXIMAL DEEP VENOUS THROMBOSIS AS ASSESSED BY MAGNETIC RESONANCE VENOGRAPHY
2002
Prevention of Venous Thromboembolism in General Surgical Patients
1988
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
National survey in the United Kingdom of prophylaxis of deep vein thrombosis for patients with fracture of the neck of the femur
2006
Intermittent pneumatic compression and deep vein thrombosis prevention
2005
The Efficacy of Pneumatic Compression Stockings in the Prevention of Pulmonary Embolism After Cardiac Surgery
1996
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients
1988
Coronary heart disease: seven dietary factors
1991 Standout
The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation
1999
Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2005
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
2005
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers
1998 Nature
The Incidence of Deep Venous Thrombosis in ICU Patients
1997
Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
1996
Pneumatic Compression Hemodynamics in Total Hip Arthroplasty
2000
Thromboprophylaxis and death after total hip replacement
1996
Fibronectin, Fibrinogen, and Laminin Act as Mediators of Adherence of Clinical Staphylococcal Isolates to Foreign Material
1988
GPIIb-IIIa: The responsive integrin
1991
Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery
2006
Prevention of Venous Thromboembolism
2004 Standout
Prospective randomized trial of sequential compression devices vs low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty
1991
Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering
2001
The use of fibrinogen uptake test in screening for deep vein thrombosis in patients with hip fracture
1990
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
1993
Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures
2004
Thromboembolic complications following radical retropubic prostatectomy Influence of external sequential pneumatic compression devices
1993
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission
1992 StandoutNobel
DEEP VENOUS THROMBOSIS FOLLOWING LUMBAR LAMINOTOMY AND LAMINECTOMY
1994
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα
1993 StandoutNatureNobel
Deep Vein Thrombosis After Major Reconstructive Spinal Surgery
1996
β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation
2002 StandoutNobel
Duplex Venous Scanning for the Prospective Surveillance of Perioperative Venous Thrombosis
1989
Protein adsorption to poly(ethylene oxide) surfaces
1991
A multimodality regimen for deep venous thrombosis prophylaxis in total knee arthroplasty
2003
Venous Thromboembolism in Spinal Cord Injury Patients
1992
Aspirin in the prevention and treatment of venous thromboembolism
2006
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology
1997
Deep venous thrombosis and pulmonary embolism after major reconstructive operations on the spine. A prospective analysis of three hundred and seventeen patients.
1994
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
1979 StandoutNatureNobel
How to Make Water Run Uphill
1992 StandoutScience
Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells.
1990 StandoutNobel
Biochemistry of Nitric Oxide and Its Redox-Activated Forms
1992 StandoutScience
α2-Adrenergic Receptor Stimulation Mobilizes Intracellular Ca2+ in Human Erythroleukemia Cells
1989
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2.
1985
Maturation of the hemostatic system during childhood
1992 Standout
Advances in engineering hydrogels
2017 StandoutScience
THROMBOPROPHYLAXIS AND DEATH AFTER TOTAL HIP REPLACEMENT
1996
Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patienis undergoing elective knee surgery
1979
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Prevention of Venous Thromboembolism
1981
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
1981
Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets
1986
Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties
1979
Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of alpha 1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.
1987 StandoutNobel
Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: Report of a randomized controlled trial
1984
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Venous Thromboembolism
1989
Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP
1978
Wetting and plasma-protein adsorption studies using surfaces with a hydrophobicity gradient
1990
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
1976 StandoutNobel
Origins and development of biomedical engineering within chemical engineering
2004
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
The role of protein kinase C in cell surface signal transduction and tumour promotion
1984 StandoutNature
Activation of purified soluble guanylate cyclase by protoporphyrin IX.
1982 StandoutNobel
Deep vein thrombosis and prostatectomy
1983
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
2002
The natural history of postoperative venous thromboemboli in gynecologic oncology: A prospective study of 382 patients
1984
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
Development of semicrystalline poly(vinyl alcohol) hydrogels for biomedical applications
1977
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
A Comparison of Intermittent Pneumatic Compression of the Calf and Whole Leg in Preventing Deep Venous Thrombosis in Urological Surgery
1997
Venous thrombosis after elective hip replacement—the influence of preventive intermittent calf compression and of surgical technique
1983
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.
1983 StandoutNobel
An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation.
1991
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
1991
Pathogenesis and Prophylaxis of Postoperative Thromboembolic Disease in Urological Pelvic Surgery
1995
A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery
1986
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
1987 StandoutScienceNobel
Effect of Delayed Admission to the Hospital on the Preoperative Prevalence of Deep-Vein Thrombosis Associated with Fractures about the Hip*
1996
Designing Cell-Compatible Hydrogels for Biomedical Applications
2012 StandoutScience
Generation of Calcium Oscillations in Fibroblasts by Positive Feedback Between Calcium and IP 3
1991 StandoutScienceNobel
Thromboembolic Prophylaxis in Moderate‐Risk Patients Undergoing Elective Abdominal Surgery: Decision and Cost‐Effectiveness Analyses
1996
Thrombin-induced protein phosphorylation in human platelets.
1975
Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
1994
Recent Advances in Venous Thromboembolic Prophylaxis During and After Total Hip Replacement
2000
Prostaglandins and Thromboxanes
1978 StandoutNobel
Regimen for improved effectiveness of intermittent pneumatic compression in deep venous thrombosis prophylaxis.
1987
Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling.
1994 StandoutNobel
Impedance Plethysmography in the Diagnosis of Asymptomatic Deep Vein Thrombosis in Hip Surgery
1991
Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots.
1978
A comparison of intermittent pneumatic compression of the calf and whole leg in preventing deep venous thrombosis in urological surgery.
1997
5-HT1A and histamine H1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools.
1991 StandoutNobel
Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip Replacement
1983
Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty.
1994
Graduated compression stockings in the prevention of venous thromboembolism
1999
Venous thromboembolism prophylaxis in gynecologic oncology: A prospective, controlled trial of low-dose heparin
1983
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
2005
Subcutaneous Heparin and Postoperative Wound Hematomas
1986
Protein adsorption and materials biocompatibility: A tutorial review and suggested hypotheses
1986
Comparison of Warfarin and External Pneumatic Compression in Prevention of Venous Thrombosis After Total Hip Replacement
1992
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
1977 StandoutNobel
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
1977
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
1986 StandoutNature
Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanism.
1992 StandoutNobel
Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis.
1992 StandoutNobel
Leukotriene A. Isolation from human polymorphonuclear leukocytes.
1980 StandoutNobel
Folding of the C-terminal bacterial binding domain in statherin upon adsorption onto hydroxyapatite crystals
2006 StandoutNobel
Calmodulin Plays a Pivotal Role in Cellular Regulation
1980 StandoutScience
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
1991
Protein adsorption from buffer and plasma onto hydrophilic—hydrophobic poly(ethylene oxide)—polystyrene multiblock copolymers
1989
Crosslinked poly(vinyl alcohol) hydrogels as swollen elastic networks
1977
Effectiveness of Intermittent Pneumatic Leg Compression for Preventing Deep Vein Thrombosis After Total Hip Replacement
1990
Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor.
1994 StandoutNobel
Vessel injury, platelet adherence, and platelet survival.
1983
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
1990 StandoutNobel
Works of Salzman Ew being referenced
Prostaglandins and platelet function.
1976
Polyethylene oxide as a biomaterial
1983
Hemostasis and Thrombosis
1995
Concurrent measurement of platelet ionized calcium concentration and aggregation: Studies with the Lumiaggregometer
1985
Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces?
1986
Interralation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3′,5′-adenosine monophosphate in human blood platelets
1977
The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
1975
Intraoperative external pneumatic calf compression to afford long-term prophylaxis against deep vein thrombosis in urological patients.
1980
Prevention of Venous Thromboembolism
1979
Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
1976
Platelet aggregation by fibrinogen polymers crosslinked across the E domain
1986
Effects Of Bay g 6575 On Platelets And On Vascular PGI2 Production
1981
Platelet volume: effect of temperature and agents affecting platelet aggregation
1969
Role of cyclic AMP in platelet function.
1972
Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots.
1978
Prevention of venous thromboembolism in orthopaedic patients
1976
Platelet-compatible hydrophilic segmented polyurethanes from polyethylene glycols and cyclohexane diisocyanate.
1982
Cuff-impedance phlebography and 125I fibrinogen scanning versus roentgenographic phlebography for diagnosis of thrombophlebitis following hip surgery. A preliminary report
1976
Activation of protein kinase C in platelets by epinephrine and A23187: correlation with fibrinogen binding
1989
Cyclic nucleotides in hemostasis and thrombosis.
1980
Polyvinyl alcohol--- heparin hydrogel "G"
1970
Inhibition of platelet function by cis-unsaturated fatty acids
1984
Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.
1987
Heterogeneity in filamentous actin content among individual human blood platelets
1992
Reduction of venous thrombosis complicating phlebography
1980